India And Singapore Create Fast Track For Generics Approval, Lifting Regulatory Process For Some Drugs
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Indian generic drug manufacturers have made another mark on the international arena by gaining faster and broader market access for their products in Singapore